BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

ArQule, Inc. 

19 Presidential Way

Woburn  Massachusetts  01801  U.S.A.
Phone: 781-994-0300 Fax: 781-376-6019


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology

Segment
Drug Discovery

Collaborations

Roche 

Pfizer Inc. 

Daiichi Sankyo, Inc. 





 Company News
ArQule, Inc. (ARQL) Announces Data Presentations With Tivantinib To Be Featured At American Society of Clinical Oncology 2014 6/2/2014 7:35:01 AM
ArQule, Inc. (ARQL) To Present At Jefferies and Co. Global Healthcare Conference 5/29/2014 8:05:49 AM
ArQule, Inc. (ARQL) Reports First Quarter 2014 Financial Results 5/7/2014 8:18:21 AM
ArQule, Inc. (ARQL) To Report First Quarter 2014 Financial Results On May 7, 2014 4/30/2014 9:14:20 AM
ArQule, Inc. (ARQL) To Present At Needham 13th Annual Healthcare Conference 4/2/2014 7:45:15 AM
ArQule, Inc. (ARQL) Reports Fiscal 2013 Year End And Fourth Quarter Results 3/5/2014 9:01:20 AM
ArQule, Inc. (ARQL) To Report Fiscal 2013 Financial Results On March 5, 2014 2/26/2014 7:39:48 AM
ArQule, Inc. (ARQL) To Present At RBC Capital Markets Healthcare Conference 2/18/2014 6:46:17 AM
ArQule, Inc. (ARQL) Announces Commencement Of Phase 3 Clinical Trial With Tivantinib In Hepatocellular Carcinoma By Partner Kyowa Hakko Kirin In Japan 2/4/2014 9:46:24 AM
ArQule, Inc. (ARQL) Soars As FDA Panel Favors Continuation Of Liver Cancer Drug Study, Stock Up +6.78% At Market Close (January 17, 2014) 1/17/2014 8:28:01 AM
12345678910...